CFP
CVS icon

Catalyst Financial Partners’s CVS Health CVS Stock Holding History

Catalyst Financial Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$596K Buy
5,760
+490
+9% +$43.7K 0.06% 188
2026
Q1 		$378K Sell
5,270
-1,386
-21% -$107K 0.04% 250
2025
Q4 		$528K Buy
6,656
+1,750
+36% +$138K 0.06% 162
2025
Q3 		$370K Buy
4,906
+105
+2% +$7.2K 0.04% 211
2025
Q2 		$331K Buy
4,801
+45
+0.9% +$2.95K 0.04% 217
2025
Q1 		$322K Buy
+4,756
New +$285K 0.06% 205
2024
Q4 		– Sell
-4,402
Closed -$277K – 274
2024
Q3 		$277K Buy
4,402
+345
+9% +$20.1K 0.05% 219
2024
Q2 		$240K Sell
4,057
-1,357
-25% -$84.9K 0.05% 219
2024
Q1 		$371K Buy
5,414
+223
+4% +$17K 0.1% 142
2023
Q4 		$410K Sell
5,191
-638
-11% -$45.4K 0.12% 118
2023
Q3 		$407K Buy
5,829
+962
+20% +$68.2K 0.13% 114
2023
Q2 		$336K Buy
4,867
+943
+24% +$67.1K 0.12% 122
2023
Q1 		$292K Sell
3,924
-606
-13% -$50.8K 0.12% 126
2022
Q4 		$422K Buy
+4,530
New +$437K 0.22% 69

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Catalyst Financial Partners's CVS Position: Q2 2026 in Review

Catalyst Financial Partners increased its CVS Health (CVS) stake by 9.3% in Q2 2026, buying an estimated $43.7K and bringing the position to 5,760 shares worth $596K. The position accounts for 0.06% of the portfolio, ranked #188.

Catalyst Financial Partners first reported a position in CVS in Q4 2022 and has held it in 14 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Catalyst Financial Partners held 5,760 shares of CVS Health worth $596K as of Q2 2026.
  • Catalyst Financial Partners bought 490 CVS Health shares in Q2 2026, an estimated $43.7K.
  • CVS Health made up 0.06% of Catalyst Financial Partners's portfolio in Q2 2026, its #188 holding.
  • Catalyst Financial Partners first reported a position in CVS Health in Q4 2022 and has held it in 14 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Catalyst Financial Partners's 13F filing for Q2 2026, filed 30 Jul 2026.